Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|December 17, 2025
Axatilimab Immunogenicity and Clinical Relevance in Patients with Chronic Graft-Versus-Host DiseaseYan-Ou Yang, Xing Liu, Breann Barker, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|January 3, 2014
Roles of the lipid metabolism in hepatic stellate cells activation △Xin-yan Jing, Xue-feng Yang, Kai Qing, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|December 30, 2016
Relation Between Cellular Senescence and Liver DiseasesGuo-Wen Li, Xue-Feng Yang, Nian Fu, et al.
Clinical Pharmacology in Drug Development|October 23, 2025
Evaluation of clinical cardiac safety of zilurgisertib, an activin receptor-like kinase-2 (ALK2) inhibitor, in healthy participantsYan-Ou Yang, Hong Yang, Xing Liu, et al.
Clinical Drug Investigation|May 17, 2025
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Axatilimab in Healthy Japanese Male Participants: Results from a Phase 1, Randomized, Double-Blind, Dose-Escalation StudyMiwa Haranaka, Kenzo Kinami, Yan-Ou Yang, et al.
British Journal of Clinical Pharmacology|December 8, 2025
Effects of Renal and Hepatic Impairment on the Pharmacokinetics of ZilurgisertibYan-Ou Yang, Yunlan Fang, Phillip Wang, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 9, 2024
Pharmacokinetics of Zilurgisertib With and Without Food from Single and Multiple Ascending Dose Phase 1 Studies in Healthy AdultsYan-Ou Yang, Xiaohua Gong, Jay Getsy, et al.
Clinical Pharmacology and Therapeutics|June 19, 2025
Exposure-Response Relationships for Axatilimab in Patients with Chronic Graft-Versus-Host DiseaseYan-Ou Yang, Alina Volkova, Victor Sokolov, et al.
Drug Metabolism and Pharmacokinetics|May 15, 2007
P450 phenotyping of the metabolism of selegiline to desmethylselegiline and methamphetamineSalete A Benetton, Che Fang, Yan-ou Yang, et al.
Clinical Pharmacology in Drug Development|June 4, 2025
Effect of Itraconazole or Rifampin on Zilurgisertib Pharmacokinetics When Administered Orally in Healthy ParticipantsYan-Ou Yang, Xiaohua Gong, Phillip Wang, et al.
Pageof 3